MedTrace Logo

Apnea Tests as the Methods of Brain Death Diagnosis.

NCT03281993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2017-09-14

No results posted yet for this study

Summary

Apnea test (AT) is the most important clinical test performed usually at the end of brain death (BD) diagnosis procedure. Traditional insufflation apnea test (I-AT) cannot be completed in patients with extremely compromised lung function due to rapid blood desaturation and circulatory disturbances. Therefore the investigators decided to verify alternative AT options such as continuous positive airway pressure apnea test (CPAP-AT) in patients with good and poor baseline oxygenation, before implementing them in currently reviewed Polish BD criteria.

Conditions

  • Brain Death
  • Apnea
  • Pupillary Anomaly

Interventions

OTHER

CPAP AT

If the investigators observe rapid desaturation defined as a decline in O2 saturation below 85%; the CPAP apnea test (CPAP-AT) test was aborted.

Sponsors & Collaborators

  • Pomeranian Medical University Szczecin

    lead OTHER

Principal Investigators

  • Joanna Pastuszka, MD PhD · Pomeranian Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-25
Primary Completion
2015-06-25
Completion
2017-06-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03281993 on ClinicalTrials.gov